BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 26469298)

  • 1. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
    de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
    J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
    Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
    Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
    Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    de Vries R; Dagelet YWF; Spoor P; Snoey E; Jak PMC; Brinkman P; Dijkers E; Bootsma SK; Elskamp F; de Jongh FHC; Haarman EG; In 't Veen JCCM; Maitland-van der Zee AH; Sterk PJ
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath.
    de Vries R; Muller M; van der Noort V; Theelen WSME; Schouten RD; Hummelink K; Muller SH; Wolf-Lansdorf M; Dagelet JWF; Monkhorst K; Maitland-van der Zee AH; Baas P; Sterk PJ; van den Heuvel MM
    Ann Oncol; 2019 Oct; 30(10):1660-1666. PubMed ID: 31529107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis.
    Tirzīte M; Bukovskis M; Strazda G; Jurka N; Taivans I
    J Breath Res; 2017 Aug; 11(3):036009. PubMed ID: 28585921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Online breath analysis using metal oxide semiconductor sensors (electronic nose) for diagnosis of lung cancer.
    Kononov A; Korotetsky B; Jahatspanian I; Gubal A; Vasiliev A; Arsenjev A; Nefedov A; Barchuk A; Gorbunov I; Kozyrev K; Rassadina A; Iakovleva E; Sillanpää M; Safaei Z; Ivanenko N; Stolyarova N; Chuchina V; Ganeev A
    J Breath Res; 2019 Oct; 14(1):016004. PubMed ID: 31505480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of Electronic Nose Technology in Sarcoidosis.
    van der Sar IG; Moor CC; Oppenheimer JC; Luijendijk ML; van Daele PLA; Maitland-van der Zee AH; Brinkman P; Wijsenbeek MS
    Chest; 2022 Mar; 161(3):738-747. PubMed ID: 34756945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma.
    Montuschi P; Santonico M; Mondino C; Pennazza G; Mantini G; Martinelli E; Capuano R; Ciabattoni G; Paolesse R; Di Natale C; Barnes PJ; D'Amico A
    Chest; 2010 Apr; 137(4):790-6. PubMed ID: 20081096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive breath monitoring with eNose does not improve glucose diagnostics in critically ill patients in comparison to continuous glucose monitoring in blood.
    Leopold JH; Bos LDJ; Colombo C; Sterk PJ; Schultz MJ; Abu-Hanna A
    J Breath Res; 2017 Apr; 11(2):026002. PubMed ID: 28260695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
    Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
    BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.